{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:23:38Z","timestamp":1774448618254,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Telethon","award":["GGP09018"],"award-info":[{"award-number":["GGP09018"]}]},{"name":"European Calcified Tissue Society PhD studentship"},{"name":"Societ\u00e0 Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro"},{"name":"National Institute of Health (NIH)","award":["R21 AR054744"],"award-info":[{"award-number":["R21 AR054744"]}]},{"name":"National Institute of Health (NIH)","award":["R01 AG041517"],"award-info":[{"award-number":["R01 AG041517"]}]},{"name":"National Institute of Health (NIH)","award":["602300"],"award-info":[{"award-number":["602300"]}]},{"name":"National Institute of Health (NIH)","award":["295181"],"award-info":[{"award-number":["295181"]}]},{"name":"SYBIL - FP7-HEALTH-2013-INNOVATION"},{"name":"INTERBONE - FP7-PEOPLE-2011-IRSES"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bone.2013.10.021","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T05:49:39Z","timestamp":1383284979000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models"],"prefix":"10.1016","volume":"59","author":[{"given":"Imranul","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie K.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid S.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Capannolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Capulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Muraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Teti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Del Fattore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.10.021_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-0004.1987.tb02774.x","article-title":"Osteopetrosis, a genetic and epidemiological study","volume":"31","author":"Bollerslev","year":"1987","journal-title":"Clin Genet"},{"key":"10.1016\/j.bone.2013.10.021_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.bone.2013.10.021_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.10.021_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00003086-199309000-00006","article-title":"Autosomal dominant osteopetrosis","volume":"294","author":"Bollerslev","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bone.2013.10.021_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1615\/CritRevEukaryotGeneExpr.v15.i2.40","article-title":"Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology","volume":"15","author":"Van Wesenbeeck","year":"2005","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.bone.2013.10.021_bb0030","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2013.10.021_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bone.2005.06.003","article-title":"Analysis of variation in expression of autosomal dominant osteopetrosis type 2: searching for modifier genes","volume":"37","author":"Chu","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.10.021_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(95)01298-2","article-title":"ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family","volume":"377","author":"Brandt","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bone.2013.10.021_bb0045","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/emboj.2011.137","article-title":"ClC-7 is a slowly voltage-gated 2Cl(\u2212)\/1H(+)-exchanger and requires Ostm1 for transport activity","volume":"30","author":"Leisle","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.bone.2013.10.021_bb0050","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/cphy.c110038","article-title":"Cell biology and physiology of CLC chloride channels and transporters","volume":"2","author":"Stauber","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bone.2013.10.021_bb0055","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.1188072","article-title":"Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl\u2212 accumulation","volume":"328","author":"Weinert","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bone.2013.10.021_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.10.021_bb0065","doi-asserted-by":"crossref","first-page":"e12585","DOI":"10.1371\/journal.pone.0012585","article-title":"The G215R mutation in the Cl\u2212\/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect","volume":"5","author":"Schulz","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2013.10.021_bb0070","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","article-title":"Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II","volume":"164","author":"Henriksen","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2013.10.021_bb0075","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.10.021_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.10.021_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1083\/jcb.200906014","article-title":"The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis","volume":"187","author":"Rucci","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2013.10.021_bb0090","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1359\/jbmr.060409","article-title":"Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties","volume":"21","author":"Chu","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.10.021_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","article-title":"Genetics, pathogenesis and complications of osteopetrosis","volume":"42","author":"Del Fattore","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.10.021_bb0100","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.10.021_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.emboj.7600576","article-title":"Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration","volume":"24","author":"Kasper","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.bone.2013.10.021_bb0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm842","article-title":"Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human","volume":"9","author":"Chalhoub","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2013.10.021_bb0115","doi-asserted-by":"crossref","first-page":"E1071","DOI":"10.1002\/humu.21167","article-title":"Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations","volume":"31","author":"Pangrazio","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bone.2013.10.021_bb0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.0954-6820.1988.tb19614.x","article-title":"Biochemical evidence of disturbed bone metabolism and calcium homeostasis in two types of autosomal dominant osteopetrosis","volume":"224","author":"Bollerslev","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.bone.2013.10.021_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"B\u00e9nichou","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.10.021_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/415287a","article-title":"X-ray structure of a ClC chloride channel at 3.0A reveals the molecular basis of anion selectivity","volume":"415","author":"Dutzler","year":"2002","journal-title":"Nature"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821300433X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821300433X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T10:26:24Z","timestamp":1646994384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821300433X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":26,"alternative-id":["S875632821300433X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.10.021","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}